Sort
39,280 grants matching “leukemia”
MCC Tumor-Specific Biomarkers: Basis for Rational Therapy of Merkel Cell Carcinom
$340,117Patrick S. Moore · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
. Methylation and silencing of human p15INK4b in acute myeloid leukemia
$340,099Linda Wolff · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
ASPECTS OF BLASTOCYST IMPLANTATION
$340,098Vanderbilt University · R37 · FY2004 · HD
Single Cell Measurement Core Facility
$340,077Gregoire Altan-Bonnet · Dana-Farber Cancer Inst · U54 · FY2012 · CA
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
$340,053Igor I Slukvin · University Of Wisconsin-Madison · R24 · FY2017 · OD
Nutrient regulation of cancer cell growth
$340,025Heather Christofk · University Of California Los Angeles · R01 · FY2019 · CA
SPORE in Lymphoma
$340,000Helen E Heslop · Baylor College Of Medicine · P50 · FY2010 · CA
Molecular Analysis of Uterine Receptivity
$340,000John P Lydon · Baylor College Of Medicine · R01 · FY2019 · HD
ROLE OF C/EBPalpha AND MYELOPOIESIS
$340,000Beth Israel Deaconess Medical Center · R01 · FY2004 · HL
Molecular Analysis of Uterine Receptivity
$340,000John P Lydon · Baylor College Of Medicine · R01 · FY2020 · HD
HuR regulates Th17 cells for promoting autoimmune neuroinflammation
$340,000Shiguang Yu · Arkansas State University · R01 · FY2015 · AI
ROLE OF C/EBPalpha AND MYELOPOIESIS
$340,000Beth Israel Deaconess Medical Center · R01 · FY2002 · HL
Interactions Between HLA Class I & Cytolytic Lymphocytes
$340,000Peter R Parham · Stanford University · R01 · FY2007 · AI
ROLE OF C/EBPalpha AND MYELOPOIESIS
$340,000Beth Israel Deaconess Medical Center · R01 · FY2001 · HL
ROLE OF C/EBPalpha AND MYELOPOIESIS
$340,000Beth Israel Deaconess Medical Center · R01 · FY2003 · HL
MKL in megakaryocytopoiesis
$339,978Diane S. Krause · Yale University · R01 · FY2011 · DK
MKL in megakaryocytopoiesis
$339,978Diane S. Krause · Yale University · R01 · FY2012 · DK
CAML in T cell Development and Function
$339,975Richard J Bram · Mayo Clinic Rochester · R01 · FY2009 · AI
CAML in T cell Development and Function
$339,975Richard J Bram · Mayo Clinic Rochester · R01 · FY2008 · AI
CAML in T cell Development and Function
$339,975Richard J Bram · Mayo Clinic Rochester · R56 · FY2007 · AI
Human Minor Histocompatibity Antigens
$339,936Jerome Ritz · Dana-Farber Cancer Inst · P01 · FY2012 · CA
Retinoic Acid Binding Proteins: Functional Studies
$339,916Lorraine J Gudas · Weill Medical Coll Of Cornell Univ · R01 · FY2007 · CA
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
$339,909Geoffrey L Uy · Washington University · P50 · FY2013 · CA
MOLECULAR CHARACTERIZATION OF ACUTE MYELOID LEUKEMIA
$339,909Stanford University · R01 · FY2002 · CA
Lenalidomide Treatment and the Chronic Lymphocytic Leukemia Microenvironment
$339,900Thomas J. Kipps · University Of California, San Diego · R21 · FY2009 · CA